This article, published as a series on "Drug Prices and Patents" in the 3 April 1965 issue of The Economic Weekly, presents the industry point of view on drug prices and patents. We present this article in the light of events that show that there is little understanding in the government on pricing of essential drugs in India. This article also contains a small excerpt from the Kefauver Committee Report on "Advanced Prices in the Drug Industry".
